Status of national immunization programs

/WEB-INF/jsp/k2web/com/cop/site/layout.jsp
eng_JW_MS_K2WT001_S

Definition of the National Immunization Program

  • Essential vaccinations (based on the Infectious Disease Control and Prevention Act), supported by local governments and carried out through public health centers and designated medical institutions. The government determines the target and timing, and supports these vaccinations.

Program implementation system

graph

Targets of national vaccinations

  • 19 types of infectious diseases for which local governments are responsible under the Infectious Disease Prevention Act for ensuring mandatory vaccination (as of June 30, 2025)

[Table 1] Infectious Diseases Subject to Mandatory Vaccinations

Infectious Diseases Subject to Mandatory Vaccinations - Category, Disease Table
Category Disease Category Disease Category Disease
1 Diphtheria 8 Epidemic parotitis 15 Hepatitis A
2 Poliomyelitis 9 Rubella 16 Human papillomavirus infection
3 Pertussis 10 Varicella 17 Group A rotavirus infection
4 Measles 11 Japanese encephalitis 18 Typhoid fever
5 Tetanus 12 Haemophilus type b 19 Hemorrhagic fever with renal syndrome
6 Tuberculosis 13 Pneumococcal
7 Hepatitis B 14 type b
In addition to the infectious diseases subject to mandatory vaccinations, COVID-19 and mpox are also being administered as temporary vaccinations supported by the state (as of June 30, 2025).

Targets of national vaccinations

[Table 2] Types of Vaccines and Targets for Infectious Diseases Subject to Mandatory Vaccination

Disease, Targets of National Vaccination Program, Type of vaccine, Target
Disease Targets of National Vaccination Program
Type of vaccine Target
Diphtheria, Tetanus, Pertussis DTaP Under 12 years old* Diphtheria, Tetanus, Pertussis
Tdap, Td 11-12 years old
Diphtheria, Tetanus, Pertussis, Poliomyelitis DTaP-IPV 2, 4, 6 months, 4-6 years
Diphtheria, Tetanus, Pertussis, Poliomyelitis Haemophilus influenzae type b DTaP-IPV/Hib 2, 4, 6 months
Diphtheria, Tetanus, Pertussis, Poliomyelitis Haemophilus influenzae type b, Hepatitis B DTaP-IPV/Hib/HepB 2, 4, 6 months
Tuberculosis BCG(intracutaneous) Within 4 weeks after birth
Hepatitis B HepB At birth, 1 month, 6 months
Poliomyelitis IPV 2, 4, 6-18 months, 4-6 years
Haemophilus influenzae type b Hib 2, 4, 6 months, 12~15 months
Pneumococcal PCV 2, 4, 6 months, 12~15 months
PPSV Those at high risk aged 2-12 years
Measles, Mumps, Rubella MMR 12-15 months, 4-6 years
Varicella VAR 12~15 months
Hepatitis A HepA 12-35 months (Second dose 6 months after the first dose)
Japanese encephalitis IJEV(inactivated vaccine) 12-23 months (second dose 1 month after the first dose), 24-35 months, 6-12 years
LJEV(live vaccine) 12~23 months, 24~35 months
Group A rotavirus infection RV1 2, 4 months
RV5 2, 4, 6 months
Pneumococcal PPSV 65+ years
Human papillomavirus infection HPV Women aged 12-17 years, low-income women aged 18-26 years
Influenza IIV 6 months to 13 years, pregnant women, 65+ years
Typhoid fever Vi antigen polysaccharide inactivated vaccine Vi antigen polysaccharide inactivated vaccine
Hemorrhagic fever with renal syndrome Inactivated vaccine Those at high risk
TOP